Castellani L, Nicaise H, Piétri J, Quilliet L, Desveaux B, Alison D, Guillou L
J Mal Vasc. 1987;12(1):64-9.
Partial interruption of inferior vena cava (I.C.V.) forms an integral part of treatment of thromboembolic disease. The most frequently used filter worldwide is currently that of Greenfield, but although its effectiveness and permeability are remarkable it can be the subject of transfixions, sliding movements and migrations. A new model of the authors' own conception is presented which eliminates these faults. The "2612" filter is based on the same concepts, but has added to it 6 lateral flanges soldered to the base of the arms, these applying pressure to the I.V.C. and ensuring its perfect positioning, and 12 hooks (6 turned downwards and 6 upwards) ensuring perfect stability. Results of a multicentre trial in 35 patients, after insertion of the "2612" filter and follow up assessment after 3 months (28 cases) by cavography and in some patients by a scan, showed permeability of 93% and total efficacy. No side effects were reported. This filter appears to represent true progress in the means of interrupting I.V.C., and further studies are contemplated.
下腔静脉部分阻断术是血栓栓塞性疾病治疗的一个重要组成部分。目前全球最常用的滤器是格林菲尔德滤器,尽管其有效性和通透性显著,但仍可能出现穿透、滑动和移位等问题。本文介绍了一种作者自行设计的新型滤器,该滤器可消除上述缺陷。“2612”滤器基于相同的理念,但在臂部底部增加了6个侧向凸缘,这些凸缘对下腔静脉施加压力,确保其完美定位;还增加了12个钩子(6个向下,6个向上),以确保完美的稳定性。在35例患者中进行的多中心试验结果显示,在植入“2612”滤器后,3个月后(28例)通过腔静脉造影以及部分患者通过扫描进行随访评估,结果显示其通透性为93%,总有效率良好。未报告任何副作用。这种滤器似乎代表了下腔静脉阻断方法的真正进步,并且正在考虑进一步的研究。